Vanguard Investments Australia
AMPH icon

Vanguard Investments Australia’s Amphastar Pharmaceuticals AMPH Stock Holding History

Vanguard Investments Australia’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Hold
8,567
– – ﹤0.01% 2171
2026
Q1 		$168K Buy
+8,567
New +$210K ﹤0.01% 2119

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Investments Australia's AMPH Position: Q2 2026 in Review

Vanguard Investments Australia held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 8,567 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Vanguard Investments Australia first reported a position in AMPH in Q1 2026 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Vanguard Investments Australia held 8,567 shares of Amphastar Pharmaceuticals worth $173K as of Q2 2026.
  • Vanguard Investments Australia left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #2171 holding.
  • Vanguard Investments Australia first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.